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Abstract  
 50 year male patient presented with a history of left nasal bleeding with discharge, left 
facial palsy for the last 15 days with uncontrolled diabetes. Black eschar was seen in nasal 
cavites with defect in hard palate on the left side (3×3cm). Debridement and cumulative 
dose (2.3gm) of amphotericin was given. 
Introduction 
 
Invasive  fungal  infections  appear  to  have  increased  over  the  past few  years,  mostly  in 
immunocompromised  patients1.  Moreover,  the  diagnosis  of  invasive  filamentous  fungal 
disease (IFFD) is often difficult in immunodeficient patients. Mucormycosis is an invasive 
fungal  infection  caused  by  various  members  of  the  class  Phycomycetes,  especially Mucoraceae, subdivided into the genera Absidia, Rhizopus and Mucor. After Aspergillosis, 
Mucormycosis is the second most common mycosis caused by filamentous fungi. Since a 
high level of mortality occurs in immunocomprised patients with IFFD2, an accurate and 
rapid  diagnosis  is  required  in  order  to  give  the  appropriate  anti-fungal  treatment.  In 
addition,  depending  on  the  isolated  fungal  species,  some  of  these  treatments  can  be 
inefficient3. The combination of two or more IFFD occurring simultaneously or sequentially 
in immunocompromised patients makes diagnosis of these patients very challenging.  
    Combined  invasive  mucormycosis  and  aspergillosis  has  been  rarely  described,  its 
occurrence has probably been underestimated4. Predisposing factors and clinical features 
in association with these mycoses are almost the same5. 
   We report a case of an associated Aspergillosis and Mucormycosis infection responsible 
for necrotic and extensive involvement of nose and paranasal sinuses in a patient with 
uncontrolled diabetes. Histopathological analysis identified Aspergillus and Mucormycoisis 
in same patient of diabetes mellitus and the patient was treated successfully. There is no 
such report mention in literature. 
Case report 
 A 50 year male patient presented with a history of left nasal bleeding with discharge (dark 
colored), discharge from oral cavity (dark colored) and left facial palsy for the last 15 days. 
He was a case of Diabetes Mellitus (on irregular treatment). On examination black eschar 
was  seen  in  both  nasal  cavites  with  defect  in  hard  palate  on  the  left  side  (3×3cm). 
Investigations  showed  uncontrolled  diabetes  and  fungal  smear  report  showed  aseptate 
hyphae. Insulin, intravenous antibiotics and physiotherapy exercises for facial palsy with 
eye  care  was  started.    Patient  was  also  started  on  empirical  intravenous  liposomal amphotericin (50-75 mg/day) on the basis of clinical suspicion and fungal smear report. 
The  subsequent biopsy  report  and fungal culture  were showed Mucormycois. The Non 
Contrast  CT  (NCCT)  of  nose  and  paranasal  sinuses  showed  soft  tissue  density  in  nasal 
cavity and maxillary sinus both side with involvement of left ethmoid and sphenoid sinus.  
   Heterogenous mass with feature of calcification was present in right nasal cavity and 
maxillary sinus, there was no intracranial involvement (figure 1, 2). The patient underwent 
Functional  endoscopic  sinus  surgery  right  side  and  Pansinusectomy  left  side  (external 
approach)  under  general  anasthesia  and  liposomal  amphotericin  was  continued 
postoperatively till a cumulative dose 2.3gm over 5week period. Final biopsy report was 
showed  Mucormycosis  with  Aspergillosis  (figure  3)  The  NCCT  scan  was  repeated  on 
completion of treatment which showed disease free nose and sinuses (figure 4). 
 Check endoscopy showed minimal crusting and subsequent biopsy report revealed no 
fungal pathology. 
     Presently  the  patient  is  under  follow-up  with  blood  sugar  control  (by  insulin)  with 
improvement in left side facial nerve palsy with healthy nasal cavities. Patient uses palatal 
obturator for palatal defect.  
Discussion 
 
Invasive  mycoses  have  long  been  recognized  as  significant  pathogens,  particularly  in 
immunocompromised patients. Rhino-orbital-cerebral form of  mycosis (ROCM) which is a 
fulminant and life threatening invasive fungal infection6 is most commonly encountered in 
patients with uncontrolled diabetes mellitis Most of the invasive mycoses are caused by 
filamentous fungi, rarely by other fungi. Of the seven different syndromes of Mucormycois 
namely the pulmonary, gastrointestinal, CNS, subcutaneous, disseminated, miscellaneous (bones, joints, heart, kidney, mediastinum) and the rhino-orbital-cerebral form, ROCM is 
the commonest in clinical practice7. The term ROCM refers to the entire spectrum ranging 
from  the  sino-nasal  tissue  invasion  (limited  sino-nasal  disease),  progression  to  orbits 
(limited  rhino-orbital  disease)  to  finally  central  nervous  system  involvement  (rhino-
orbital-cerebral  disease)8.  ROCM  is  generally  encountered  in  the  settings  of  diabetic 
ketoacidosis, hematological malignancies, severe burns, renal or hepatic disease, AIDS and 
organ  transplant  recipients9.  Smith  and  Krichner10  gave  the  following  criteria  for  the 
clinical diagnosis of Mucormycosis: (i) a blood tinged nasal discharge and facial pain, both 
on the same side, (ii) soft peri-orbital or peri-nasal swelling, going on to discoloration, 
induration and progressive vascular occlusion, (iii) ptosis of the eyelid, proptosis of the 
eyeball and complete ophthalmoplegia, (iv) multiple unrelated cranial nerve palsies, and 
(v) black, necrotic turbinates, easily mistaken for dried, crusted blood. Clinical examination 
in  patient of Aspergillosis  reveals grayish brown fungal ball or  grayish white color cheesy 
mass  in  nasal  cavities.  The  typical  clinical  features  of  ROCM  are  as  a  consequence  of 
invasion, thrombosis and necrosis of the underlying tissue. Pathological identification of 
the hyphae is based on different well-described criteria: diameter, presence of septa, and 
branching angle (right or acute branching), pigmentation. It is important to consider the 
characteristics of the infiltrate at the inflammatory region that is in contact with hyphae: 
presence of angioinvasion, of giant cells and of eosinophilic necrosis. The most common 
fungi associated with ROCM are the Mucor, Rhizopus, Rhizomucor and Absidia. In cases of 
Aspergillosis , most common fungi are aspergillus fumigatous and flavus. The spores of 
these  saprophytic  fungi  germinate  favorably  in  an  environment  of  low  oxygen,  high 
glucose, acidic medium and high iron levels11.        Rhino-orbito-cerebral form of invasive Mycosis with coexisting Aspergillosis in diabetes 
mellitus is not quoted in literature. In our patient coexisting facial nerve palsy have been 
due to simultaneous presentation of Bell’s palsy or diabetic neuropathy. 
    Diagnosis of Mucormycosis requires a high index of suspicion in the relevant clinical 
setting.  The  differential  diagnoses  in  such  clinical  setting  include  septic  emboli, 
atherosclerotic vasculopathy, vasculitis, local streptococcal and clostridial infection, and 
invasive Aspergillosis. 
  An early diagnosis, prompt institution of antifungal therapy (amphotericin) with timely 
surgical  debridement  is  the  key  to  survival  in  cases  of  invasive  mycosis.  Correction  of 
underlying disorder is of paramount importance. Survival rates in ROCM have ranged from 
21-70% in the past but are steadily improving with aggressive management strategies. 
Treatment outcome is good when the disease is anatomically confined to the sinuses. In 
other cases the disease carries a very high mortality with conservative treatment alone12. . 
      Simultaneous  presentation  of  mucormycosis  with  aspergillosis  is  not  mentioned  in 
literature of cases of diabetes mellitus. We are the first to discuss over experience with readers. 
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Figure  1  Preoperative NCCT scan coronal view    
 
 
 
                                                 
Figure 2  Preoperative NCCT –axial view  
 
Figure  3  Histopathological view    
 
                                                                  
Figure  4  Post surgery coronal view                                    
 
 
 
 
 